Remove common-pharma-interest modernizing-therapeutic-cell-production
article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

In comparison to traditional large-scale manufacturing operations, decentralized modes of manufacturing can be more agile, more transportable, and tailored for specific modalities or production processes. These new operating models can help enable and accelerate the efforts of Pharma 4.0™

article thumbnail

Enabling Global Pharma Innovation: Delivering for Patients

ISPE

It is incumbent for industry to modernize manufacturing processes to improve efficiency and increase confidence in quality assurance for the benefit of patients while introducing novel technology and modalities as the science advances.

FDA 52
article thumbnail

Environmental Sustainability in Biopharmaceutical Facility Design

ISPE

While the term sustainability encompasses a wide scope of goals, in examining manufacturing environmental sustainability we address reducing environmental burdens and progressing to more circular economies throughout the product and manufacturing process life cycle. 7 An integrative (vs. 7 An integrative (vs. 7 An integrative (vs.